Independent radiologic review of the Gynecologic Oncology Group Study 0218, a phase III trial of bevacizumab in the primary treatment of advanced epithelial ovarian, primary peritoneal, or fallopian tube cancer: methodological comment

 

Authors

  • G. Daniele Clinical Trials Unit, Istituto Nazionale Tumori IRCCS “Fondazione G. Pascale”, Napoli, Italy.
  • M. Di Maio Clinical Trials Unit, Istituto Nazionale Tumori IRCCS “Fondazione G. Pascale”, Napoli, Italy.
  • M.C. Piccirillo Clinical Trials Unit, Istituto Nazionale Tumori IRCCS “Fondazione G. Pascale”, Napoli, Italy.

Abstract

No abstract available